Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Barclays analyst Andrew Mok maintains RadNet (NASDAQ:RDNT) with a Overweight and raises the price target from $60 to $79.
Truist Securities analyst David Macdonald maintains RadNet (NASDAQ:RDNT) with a Buy and raises the price target from $74 to ...
Raymond James analyst John Ransom reiterates RadNet (NASDAQ:RDNT) with a Strong Buy and raises the price target from $66 to ...
RadNet (NASDAQ:RDNT) reported quarterly earnings of $0.31 per share which beat the analyst consensus estimate of $0.16 by 97.45...
Program will increase access to cutting-edge AI-powered breast cancer detection and is designed to boost compliance with annual...
B. Riley Securities analyst Yuan Zhi initiates coverage on RadNet (NASDAQ:RDNT) with a Buy rating and announces Price Target...
See-Mode's commercially available AI-powered ultrasound detection, characterization, and reporting solutions for thyroid an...
